Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1983-08-12
1985-04-30
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544 586, 544131, 544364, 544365, 546193, 546194, 546256, 546261, 546316, 514222, 514234, 514318, 514335, 514343, 514355, A61K 31455, C07D40112
Patent
active
045144087
ABSTRACT:
N-substituted nicotinamide 1-oxide having histamine H.sub.2 receptor blocking activity of formula ##STR1## wherein X is a nitrogen atom or a CH group and Am represents a mono- or disubstituted amino group, a pyrrolidino, morpholino, thiomorpholino, hexamethyleneimino group, or an optionally substituted piperidino or piperazino group; their salts; a process for their preparation; and pharmaceutical compositions containing them as active ingredients.
REFERENCES:
patent: 4309433 (1982-01-01), Hirai et al.
Bickel, M., Pharm. Rev., 21(4), p. 348, (1969).
Boveri Sergio
Nisato Dino
Sanofi
Schwartz Richard A.
LandOfFree
N-substituted nicotinamide 1-oxide as histamine H.sub.2 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted nicotinamide 1-oxide as histamine H.sub.2 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted nicotinamide 1-oxide as histamine H.sub.2 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1967941